Episode
The one-man biotech is only 10 years away - a16z-backed founder Kexin Huang
- Podcast
- Free Radicals
- Published
- Apr 14, 2026
- Duration seconds
- 4241
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/free-radicals-7588534/episodes/the-one-man-biotech-is-only-10-years-away-a16z-backed-founder-kexin-huang/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/free-radicals-7588534/the-one-man-biotech-is-only-10-years-away-a16z-backed-founder-kexin-huang.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Today’s guest is Kexin Huang. Kexin recently raised $13.5M from Andreessen Horowitz and Menlo Ventures in partnership with Anthropic, to build Phylo - a research lab studying agentic biology. Phylo’s first product is Biomni, the world’s first open source IBE or Integrated Biology Environment for conducting agentic biology research. They intend to do for biology what the IDE did for software. Kexin completed his PhD in Computer Science at Stanford, where he was advised by Jure Leskovec on artificial intelligence for healthcare and biology. As a PhD student Kexin garnered over 10,000 citations, published in Nature and earned six best paper awards at leading machine learning conferences, all this before the age of 30. Kexin has earned a reputation as one of the brightest minds in AI for life sciences. You’ll see why in today’s conversation.